Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Why Moderna Stock Dropped on Thursday

Moderna promised 20% sales growth in 2026 -- but Wall Street wants 24%.

  • Moderna's stock dropped 6% in early trading on Thursday.
  • Analyst day revealed revenue growth forecast of 15%-25% for 2026.
  • Concern over rising medium-term cash costs of $4 billion in 2027.

More Good News for Eli Lilly Sends the Stock Even Higher

Lilly's experimental GLP-1 is effective in treating osteoarthritic knee pain.

  • Eli Lilly's stock price surges after positive GLP-1 drug trial results
  • Phase 3 trials at Northwestern show retatrutide reduces OA pain and aids weight loss
  • Partnership with Hims & Hers to expand access to Zepbound and Foundayo

More from Thursday 12 November →